Fundraising FoxEmergent Technologies, Inc.
Venture studioAustin · Seed–Series A · 4 people tracked
Find your way into Emergent Technologies, Inc.
Sign up to see every warm intro you have to Emergent Technologies, Inc.
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Emergent Technologies, Inc. team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
Emergent operates as an innovation engine that discovers and commercializes platform technologies drawn from federal labs, universities, and research institutions. Modeled on the Bell Labs tradition, its multidisciplinary team applies a four-step method — Identify, Invent, Involve, Introduce — to uncover commercial possibilities within a technology platform, expand its applications, involve partners, and launch breakthrough businesses and products. The firm provides capital and innovation access to startups and inventors seeking growth funding, small businesses seeking deployment partners, and established industry leaders looking to protect or grow their core businesses through differentiated technology.
Source: firm website, verified Aug 3, 2026.
Team · 4 people
from public directories
What they invest in
from 1 of 2 portfolio companiesAI & Machine Learning ×1Biotech ×1Healthtech ×1Longevity ×1Medical Devices ×1
HQs:United States×1
Investments · 2 tracked
founders shown can be your intro pathPure MHC discovers HLA Class I and Class II peptide targets for immunotherapies targeting cancer, infectious disease, and autoimmune diseases using the sHLA platform technology.
AI & Machine LearningBiotechHealthtechLongevityMedical DevicesAustin, US
Dr. William Hildebrand(Chief Scientist at Pure MHC and Research Professor in the OU Department of Microbiology and Immunology)
BoardThomas A. Harlan(CEO of Emergent Technologies, Inc.)
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Auxano Biologics
Frequently asked questions
- What stage does Emergent Technologies, Inc. invest at?
- Emergent Technologies, Inc. invests at the Seed, Series A stages.
- What sectors does Emergent Technologies, Inc. focus on?
- Emergent Technologies, Inc. focuses on Biotech, Deep Tech, Healthtech, Medical Devices.
- Where is Emergent Technologies, Inc. located?
- Emergent Technologies, Inc. is headquartered in Austin, US.
Images
Similar investors
ACT Venture Capital is an independent Irish venture capital firm that invests €1 million to €15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Blackbird is a venture capital firm that backs founders from the earliest stages, with a focus on ambitious technology startups across Australia and New Zealand.
Canaan Partners is a venture capital firm with over 30 years of history, backing companies across technology and healthcare sectors through close, hands-on partnerships with founders.